165 related articles for article (PubMed ID: 33799680)
1. Garcinol Encapsulated Ph-Sensitive Biodegradable Nanoparticles: A Novel Therapeutic Strategy for the Treatment of Inflammatory Bowel Disease.
Jacob EM; Borah A; Pillai SC; Kumar DS
Polymers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799680
[TBL] [Abstract][Full Text] [Related]
2. Oral targeted delivery of Imatinib by pH responsive copolymer modulates liver fibrosis in the mice model.
Siapoush S; Mousazadeh H; Rezaei R; Hatami B; Mazhari S; Hashemi N; Reza Zali M; Baghaei K
Int J Pharm; 2023 Jun; 641():123068. PubMed ID: 37225027
[TBL] [Abstract][Full Text] [Related]
3. pH-Sensitive Nanoparticles for Colonic Delivery Anti-miR-301a in Mouse Models of Inflammatory Bowel Diseases.
Wang J; Yao M; Zou J; Ding W; Sun M; Zhuge Y; Gao F
Nanomaterials (Basel); 2023 Oct; 13(20):. PubMed ID: 37887947
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis.
Zhou H; Qian H
Drug Des Devel Ther; 2018; 12():2601-2609. PubMed ID: 30174414
[TBL] [Abstract][Full Text] [Related]
5. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
6. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
7. Optimizing pH-sensitive and time-dependent polymer formula of colonic pH-responsive pellets to achieve precise drug release.
Song L; Liang L; Shi X; Chen H; Zhao S; Chen W; Zhou R; Zhao W
Asian J Pharm Sci; 2019 Jul; 14(4):413-422. PubMed ID: 32104470
[TBL] [Abstract][Full Text] [Related]
8. Rhein laden pH-responsive polymeric nanoparticles for treatment of osteoarthritis.
Hu B; Gao F; Li C; Zhang B; An M; Lu M; Liu Y; Liu Y
AMB Express; 2020 Aug; 10(1):158. PubMed ID: 32865763
[TBL] [Abstract][Full Text] [Related]
9. Colon-targeted delivery of tacrolimus using pH-responsive polymeric nanoparticles for murine colitis therapy.
Cai X; Wang X; He M; Wang Y; Lan M; Zhao Y; Gao F
Int J Pharm; 2021 Sep; 606():120836. PubMed ID: 34217824
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma.
Paul B; Gaonkar RH; Dutta D; Dasi R; Mukherjee B; Ganguly S; Das SK
Biomater Adv; 2022 Mar; 134():112714. PubMed ID: 35581094
[TBL] [Abstract][Full Text] [Related]
11. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
12. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.
Leonard F; Srinivasan S; Liu X; Collnot EM; Ferrari M; Lehr CM; Godin B
Eur J Pharm Biopharm; 2020 Jun; 151():61-72. PubMed ID: 32283213
[TBL] [Abstract][Full Text] [Related]
13. Colon-specific delivery of methotrexate using hyaluronic acid modified pH-responsive nanocarrier for the therapy of colitis in mice.
Lv Y; Ren M; Yao M; Zou J; Fang S; Wang Y; Lan M; Zhao Y; Gao F
Int J Pharm; 2023 Mar; 635():122741. PubMed ID: 36804523
[TBL] [Abstract][Full Text] [Related]
14. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
16. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
17. Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease.
Zeeshan M; Ali H; Khan S; Mukhtar M; Khan MI; Arshad M
Nanomedicine (Lond); 2019 Aug; 14(15):1945-1969. PubMed ID: 31355705
[No Abstract] [Full Text] [Related]
18. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
[TBL] [Abstract][Full Text] [Related]
19. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.
Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H
Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691
[TBL] [Abstract][Full Text] [Related]
20. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
